Main Content

Press Release


INVITATION: ELEKTA’S INTERIM REPORT MAY-JULY 2009/10

Stockholm, September 8, 2009

Elekta’s interim report for the first three months 2009/10 will be published on September 15 with the following schedule:

- The report will be published on September 15 at around 13.00 CET.

- Elekta will host a telephone conference 18.00-18.40 CET on September 15 with CEO Tomas Puusepp and CFO Håkan Bergström. Since the AGM is held the same day there is limited time for the conference call. We have therefore decided to focus on questions and answers.

To take part in the conference call, please dial in about ten minutes in advance.

- Swedish dial-in number: +46 (0)8 5052 0110
- UK dial-in number: +44 (0)20 7162 0077
- US dial-in number: + 1 334 323 6201

The telephone conference will be broadcasted over the Internet (audio only). Please visit http://www.elekta.com/events_investor_events.php.

A replay of the telephone conference will be available until September 22. Please dial Sweden: +46 (0)8 5052 0333, UK: +44 (0)20 7031 4064, US: +1 954 334 0342, and use access code 845200.

******

For further information, please contact:

Stina Thorman, Investor Relations, Elekta AB
Tel: +46 8 587 254 37 +46 70 778 6010, e-mail: stina.thorman@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


This information was brought to you by Cision http://www.cisionwire.com

The following files are available for download:


PDF